Charles Cliff Duncan
At a glance: Charles Cliff Duncan is Director at Vanda Pharmaceuticals (VNDA). Their latest SEC Form 4, filed Nov 5, 2026, reported a purchase of $3K. On file: 3 purchase lines ($38K) and 0 sale lines ($0).
Disclosed holdings: about $434K of VNDA stock: 108,701 shares reported on their latest Form 4 (filed Nov 5, 2026), valued at the Nov 13, 2026 close of $3.99. This counts only VNDA shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Vanda Pharmaceuticals Inc. (VNDA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 5SEC | VNDAVanda Pharmaceuticals Inc.First buyBefore earnings | Buy | 75099,451 held (+1%) | $3.80 | $3K | +5.1% |
| Nov 5SEC | VNDAVanda Pharmaceuticals Inc.First buy | Buy | 3,447102,898 held (+3%) | $3.82 | $13K | +4.4% |
| Nov 5SEC | VNDAVanda Pharmaceuticals Inc.First buy | Buy | 5,803108,701 held (+6%) | $3.80 | $22K | +4.9% |
- Buy
Director Charles Cliff Duncan bought $3K of VNDA at $3.80 — first open-market purchase in our records.
- Buy
Director Charles Cliff Duncan bought $13K of VNDA at $3.82 — largest purchase by this insider in our records.
- Buy
Director Charles Cliff Duncan bought $22K of VNDA at $3.80 — largest purchase by this insider in our records.
Follow Charles Cliff Duncan
Get one email when Charles Cliff Duncan files a new purchase or sale. Free.
At most one email a day about Charles Cliff Duncan, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.